Events

Webinar – How to prepare a successful innovation procurement proposal for Horizon Europe
JUN
Tue
22
14:00 - 16:00

This was 4 years ago

Location

Online only

Programmes
Horizon Europe HorizonEU L+F

The European Commission is organising an open information session to inform all potential applicants to Horizon Europe calls on the modalities for preparing Pre-Commercial Procurement (PCP) or Public Procurement of Innovative solutions (PPI) type proposals.

This session will complement the webinar organised on 24 March on ‘How to prepare a successful proposal’. It will focus on the specificities of preparing this type of project proposal.

This Horizon Europe webinar will take place via livestream from 14.00 CEST so no registration is needed. The livestream will be available here. The webinar will be recorded so you can also watch it a later time and the presentations will also be uploaded to the same webpage. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.